These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38004334)

  • 21. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.
    Meulendyke KA; Queen SE; Engle EL; Shirk EN; Liu J; Steiner JP; Nath A; Tarwater PM; Graham DR; Mankowski JL; Zink MC
    J Neurovirol; 2014 Dec; 20(6):591-602. PubMed ID: 25227932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
    Kamal S; Locatelli I; Wandeler G; Sehhat A; Bugnon O; Metral M; Du Pasquier R; Gutbrod K; Cavassini M; Schneider MP;
    Open Forum Infect Dis; 2017; 4(2):ofx070. PubMed ID: 28584853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep Disturbances and Chronic Pain in People with HIV: Implications for HIV-Associated Neurocognitive Disorders.
    Cody SL; Hobson JM; Gilstrap SR; Thomas SJ; Galinat D; Goodin BR
    Curr Sleep Med Rep; 2022 Dec; 8(4):124-131. PubMed ID: 36687512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
    Kaul M
    Curr Opin Neurol; 2009 Jun; 22(3):315-20. PubMed ID: 19300249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer.
    Jorgensen MM; de la Puente P
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.
    Jensen BK; Monnerie H; Mannell MV; Gannon PJ; Espinoza CA; Erickson MA; Bruce-Keller AJ; Gelman BB; Briand LA; Pierce RC; Jordan-Sciutto KL; Grinspan JB
    J Neuropathol Exp Neurol; 2015 Nov; 74(11):1093-118. PubMed ID: 26469251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV, antiretroviral therapies, and the brain.
    Liner KJ; Ro MJ; Robertson KR
    Curr HIV/AIDS Rep; 2010 May; 7(2):85-91. PubMed ID: 20425562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The delicate balance between neurotoxicity and neuroprotection in the context of HIV-1 infection.
    Sénécal V; Barat C; Tremblay MJ
    Glia; 2021 Feb; 69(2):255-280. PubMed ID: 32910482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The far-reaching HAND of cART: cART effects on astrocytes.
    Gonzalez H; Podany A; Al-Harthi L; Wallace J
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV and antiretroviral therapy in the brain: neuronal injury and repair.
    Ellis R; Langford D; Masliah E
    Nat Rev Neurosci; 2007 Jan; 8(1):33-44. PubMed ID: 17180161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HAND Database: a gateway to understanding the role of HIV in HIV-associated neurocognitive disorders.
    Griffin TZ; Kang W; Ma Y; Zhang M
    BMC Med Genomics; 2015 Oct; 8():70. PubMed ID: 26510927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders.
    Cheney L; Guzik H; Macaluso FP; Macian F; Cuervo AM; Berman JW
    Cells; 2020 Jun; 9(6):. PubMed ID: 32526847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Associated Neurocognitive Disorders Subsidence Through Citalopram Addition in Anti-retroviral Therapy (HANDS-CARE): A Concept Note.
    Ojagbemi A
    Front Neurol; 2021; 12():658705. PubMed ID: 34381409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder.
    Chu L; Shu Z; Gu X; Wu Y; Yang J; Deng H
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):445-463. PubMed ID: 36745405
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology.
    Thompson LJ; Genovese J; Hong Z; Singh MV; Singh VB
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of leukemia inhibitory factor as a therapeutic for permanent large vessel stroke differs among aged male and female rats.
    Davis SM; Collier LA; Goodwin S; Lukins DE; Powell DK; Pennypacker KR
    Brain Res; 2019 Mar; 1707():62-73. PubMed ID: 30445025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CNS Neurotoxicity of Antiretrovirals.
    Lanman T; Letendre S; Ma Q; Bang A; Ellis R
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):130-143. PubMed ID: 31823251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-content analysis and Kinetic Image Cytometry identify toxicity and epigenetic effects of HIV antiretrovirals on human iPSC-neurons and primary neural precursor cells.
    Smith AS; Ankam S; Farhy C; Fiengo L; Basa RCB; Gordon KL; Martin CT; Terskikh AV; Jordan-Sciutto KL; Price JH; McDonough PM
    J Pharmacol Toxicol Methods; 2022; 114():107157. PubMed ID: 35143957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.